Johnson & Johnson unit recalls 43 medicines

The recall was announced after FDA inspectors identified "manufacturing deficiencies" in the company's Fort Washington, Pa., plant.

According to senior FDA official Douglas Stearn, the plant's manufacturing process was "not in control," a term regulators use to describe flawed procedures that affect the composition of medicine.

The recall, which is undertaken by McNeil Consumer Healthcare, affects hundreds of thousands of bottles of medicine in homes and on store shelves throughout the U.S. and in nine other countries.

It includes medicines manufactured in United States, and sold in United States, Canada, Dominican Republic, Dubai (UAE), Fiji, Guam, Guatemala, Jamaica, Puerto Rico, Panama, Trinidad & Tobago, and Kuwai; Kazinform cites Xinhua.

See www.xinhuanet.com/english2010 for full version